Comprehensive explanation of abatacept (Enresu) injection method and precautions during injection

Abatacept is a selective T cell costimulation modulator, mainly used for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) and other autoimmune diseases. Abatacept can be administered by intravenous injection (IV) or subcutaneous (SC) injection. The choice of injection method needs to be determined based on the patient's condition, physician's advice and own conditions. Intravenous injections are usually performed in hospitals or medical institutions and are operated by professional medical staff; subcutaneous injections can be completed at home, but patients or caregivers need to receive sufficient training to ensure standardized and safe operations.

In terms of intravenous injection, abatacept needs to be dosed according to body weight and infused slowly, usually within 30 minutes to 1 hour. Before injection, the appearance of the medicinal solution should be checked to confirm that there is no turbidity, sedimentation or particulate matter, and the use of abnormal medicinal solutions should be avoided. During the infusion process, patients should be observed for allergic reactions such as fever, chills, rash or respiratory symptoms. Once an abnormality occurs, the infusion should be stopped immediately and corresponding measures should be taken. At the same time, the incident should be recorded and the doctor should be notified. After intravenous injection, patients generally need to stay in a medical institution for a certain period of time for observation in order to respond to possible infusion reactions in a timely manner.

When injected subcutaneously, abatacept is usually administered in a prefilled syringe or auto-injection pen. The injection site should be chosen on the outside of the abdomen, thigh, or upper arm to avoid areas near scars, rashes, or infections. Before each injection, the skin should be cleaned with alcohol cotton balls and allowed to dry before injecting. During the injection process, the patient should keep the needle vertically inserted into the skin, slowly inject the liquid, and press the injection site for a few seconds after completion to reduce leakage and pain. Injection sites should be rotated to avoid skin induration or irritation caused by repeated use of the same area over a long period of time.

Precautions during abatacept injection also include medication storage, dosing compliance, and safe administration. The drug should be stored in a refrigerator at 2℃ to 8℃ to avoid freezing and direct sunlight; it needs to be returned to room temperature before injection, but not more than 24 hours. Patients should strictly follow the dosage and injection interval prescribed by the doctor, and do not increase or decrease the dosage or change the injection frequency without authorization. During use, signs of infection, allergic reactions and other adverse events need to be closely observed, and blood routine and liver and kidney function should be followed up regularly. Through standardized injection operations and scientific management, abatacept can effectively control the activity of autoimmune diseases while minimizing the risk of adverse reactions.

Reference link:https://www.drugs.com